Kento Inada

7PUBLICATIONS
14CO-AUTHORS
Haematological tumoursRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 05, 2024
A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1-JNK pathway-dependent chemokines.

Keiya Watakabe, Masato Miyoshi, Sei Kakinuma

|Nov 21, 2022
Simple algorithm to narrow down the candidates to receive echocardiography in patients with chronic liver disease for suspected pulmonary hypertension.

Koji Yamashita, Masayuki Kurosaki, Hiroyuki Nakanishi

|May 23, 2022
Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment.

Shun Kaneko, Kaoru Tsuchiya, Yutaka Yasui

|May 19, 2022
Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease.

Kento Inada, Nobuharu Tamaki, Masayuki Kurosaki

|Sep 29, 2021
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis.

Kento Inada, Shun Kaneko, Masayuki Kurosaki

|Jun 21, 2021
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease.

Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi

Pageof 2